133 related articles for article (PubMed ID: 21566422)
1. All-cause health care charges among managed care patients with constipation and comorbid irritable bowel syndrome.
Mitra D; Davis KL; Baran RW
Postgrad Med; 2011 May; 123(3):122-32. PubMed ID: 21566422
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study.
Paré P; Gray J; Lam S; Balshaw R; Khorasheh S; Barbeau M; Kelly S; McBurney CR
Clin Ther; 2006 Oct; 28(10):1726-35; discussion 1710-1. PubMed ID: 17157129
[TBL] [Abstract][Full Text] [Related]
3. The spectrum of irritable bowel syndrome: A clinical review.
Gilkin RJ
Clin Ther; 2005 Nov; 27(11):1696-709. PubMed ID: 16368443
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life, work productivity and health care resource use associated with constipation predominant irritable bowel syndrome.
DiBonaventura M; Sun SX; Bolge SC; Wagner JS; Mody R
Curr Med Res Opin; 2011 Nov; 27(11):2213-22. PubMed ID: 21951105
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive assessment of patients with irritable bowel syndrome with constipation and chronic idiopathic constipation using deterministically linked administrative claims and patient-reported data: the Chronic Constipation and IBS-C Treatment and Outcomes Real-World Research Platform (CONTOR).
Taylor DCA; Abel JL; Martin C; Doshi JA; Essoi B; Korrer S; Reasner DS; Carson RT; Hunter AG
J Med Econ; 2020 Oct; 23(10):1072-1083. PubMed ID: 32696684
[TBL] [Abstract][Full Text] [Related]
6. Opioid use patterns and health care resource utilization in patients prescribed opioid therapy with and without constipation.
Iyer S; Davis KL; Candrilli S
Manag Care; 2010 Mar; 19(3):44-51. PubMed ID: 20361548
[TBL] [Abstract][Full Text] [Related]
7. Healthcare costs among patients with chronic constipation: a retrospective claims analysis in a commercially insured population.
Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT; Doshi JA
J Med Econ; 2014 Feb; 17(2):148-58. PubMed ID: 24168640
[TBL] [Abstract][Full Text] [Related]
8. A case-control comparison of direct healthcare-provider medical costs of chronic idiopathic constipation and irritable bowel syndrome with constipation in a community-based cohort.
Herrick LM; Spalding WM; Saito YA; Moriarty J; Schleck C
J Med Econ; 2017 Mar; 20(3):273-279. PubMed ID: 27783533
[TBL] [Abstract][Full Text] [Related]
9. Comorbidity and use of health-care services among irritable bowel syndrome sufferers.
Hillilä MT; Siivola MT; Färkkilä MA
Scand J Gastroenterol; 2007 Jul; 42(7):799-806. PubMed ID: 17558902
[TBL] [Abstract][Full Text] [Related]
10. Utilization patterns and net direct medical cost to Medicaid of irritable bowel syndrome.
Martin BC; Ganguly R; Pannicker S; Frech F; Barghout V
Curr Med Res Opin; 2003; 19(8):771-80. PubMed ID: 14687449
[TBL] [Abstract][Full Text] [Related]
11. Costs of health care for irritable bowel syndrome, chronic constipation, functional diarrhoea and functional abdominal pain.
Nyrop KA; Palsson OS; Levy RL; Von Korff M; Feld AD; Turner MJ; Whitehead WE
Aliment Pharmacol Ther; 2007 Jul; 26(2):237-48. PubMed ID: 17593069
[TBL] [Abstract][Full Text] [Related]
12. The economic burden of treatment failure amongst patients with irritable bowel syndrome with constipation or chronic constipation: a retrospective analysis of a Medicaid population.
Guerin A; Carson RT; Lewis B; Yin D; Kaminsky M; Wu E
J Med Econ; 2014 Aug; 17(8):577-86. PubMed ID: 24811855
[TBL] [Abstract][Full Text] [Related]
13. A retrospective and prospective 12-month observational study of the socioeconomic burden of moderate to severe irritable bowel syndrome with constipation in Spain.
Mearin F; Caballero AM; Serra J; Brotons C; Tantiñà A; Fort E; Martínez-Cerezo FJ; Perelló A; Sánchez-Antolín G; Rey E; Angós Musgo R; Berdier R; Gómez-Rodríguez B; Clavé P; García-Alonso M; Torán-Monserrat P; Tack J
Gastroenterol Hepatol; 2019 Mar; 42(3):141-149. PubMed ID: 30612850
[TBL] [Abstract][Full Text] [Related]
14. The spectrum of constipation-predominant irritable bowel syndrome and chronic idiopathic constipation: US survey assessing symptoms, care seeking, and disease burden.
Heidelbaugh JJ; Stelwagon M; Miller SA; Shea EP; Chey WD
Am J Gastroenterol; 2015 Apr; 110(4):580-7. PubMed ID: 25781368
[TBL] [Abstract][Full Text] [Related]
15. Budget impact of tegaserod on a managed care organization formulary.
Bloom MA; Barghout V; Kahler KH; Bentkover J; Kurth H; Gralnek IM; Spiegel BM
Am J Manag Care; 2005 Apr; 11(1 Suppl):S27-34. PubMed ID: 15926761
[TBL] [Abstract][Full Text] [Related]
16. The economic consequences of irritable bowel syndrome: a US employer perspective.
Leong SA; Barghout V; Birnbaum HG; Thibeault CE; Ben-Hamadi R; Frech F; Ofman JJ
Arch Intern Med; 2003 Apr; 163(8):929-35. PubMed ID: 12719202
[TBL] [Abstract][Full Text] [Related]
17. Total costs of IBS: employer and managed care perspective.
Cash B; Sullivan S; Barghout V
Am J Manag Care; 2005 Apr; 11(1 Suppl):S7-16. PubMed ID: 15926759
[TBL] [Abstract][Full Text] [Related]
18. Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III.
Ersryd A; Posserud I; Abrahamsson H; Simrén M
Aliment Pharmacol Ther; 2007 Sep; 26(6):953-61. PubMed ID: 17767480
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, bowel habit subtypes and medical care-seeking behaviour of patients with irritable bowel syndrome in Northern Greece.
Katsinelos P; Lazaraki G; Kountouras J; Paroutoglou G; Oikonomidou I; Mimidis K; Koutras C; Gelas G; Tziomalos K; Zavos C; Pilpilidis I; Chatzimavroudis G
Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):183-9. PubMed ID: 19212207
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the alternating bowel habit subtype in patients with irritable bowel syndrome.
Tillisch K; Labus JS; Naliboff BD; Bolus R; Shetzline M; Mayer EA; Chang L
Am J Gastroenterol; 2005 Apr; 100(4):896-904. PubMed ID: 15784038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]